Literature DB >> 19816707

Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men.

Jin-Kyung Cho1, Tae-Kyung Han, Hyun-Sik Kang.   

Abstract

Little information is available regarding how body fatness and cardio/respiratory fitness (CRF) are associated with serum vaspin. The purpose of the study was to investigate the combined effect of body mass index (BMI) and CRF on serum vaspin in Korean young men. In a cross-sectional study, we examined 490 Korean young men (mean age 23.8 +/- 2.5 years) who were voluntarily recruited. Body fatness and fasting levels of serum insulin, adiponectin, and vaspin were measured. CRF was quantified as the minute volume of oxygen consumption (VO(2)) measured during a graded treadmill test. We assigned individuals to either low or middle or high third CRF tertiles based on age-adjusted VO(2max). We also assigned individuals to either a lean weight (LN) or obese (OB) group based on body fatness levels, in which a BMI value >/=25 kg/m(2) was used as an indicator of Pacific-Asian obesity. Group analyses showed significant interaction effects between fatness and CRF on fasting insulin and serum vaspin such that the OB group with low CRF levels had significantly higher insulin and vaspin concentrations than the OB counterparts with moderate to high CRF levels, and no such CRF-based sub-group differences in insulin and vaspin were found in the LN groups. Regression analyses show that BMI, waist circumference, VO(2), and fasting insulin explain approximately 18% of the individual variations in serum vaspin concentration in this study population. This is the first study to show that high body fatness along with low CRF might contribute to increased vaspin concentrations in Korean young men.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816707     DOI: 10.1007/s00421-009-1238-8

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  23 in total

1.  Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes.

Authors:  Nora Klöting; Janin Berndt; Susan Kralisch; Peter Kovacs; Mathias Fasshauer; Michael R Schön; Michael Stumvoll; Matthias Blüher
Journal:  Biochem Biophys Res Commun       Date:  2005-11-15       Impact factor: 3.575

2.  Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.

Authors:  Janin Berndt; Nora Klöting; Susan Kralisch; Peter Kovacs; Mathias Fasshauer; Michael R Schön; Michael Stumvoll; Matthias Blüher
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

3.  Lifestyle behaviors associated with lower risk of having the metabolic syndrome.

Authors:  Shankuan Zhu; Marie-Pierre St-Onge; Stanley Heshka; Steven B Heymsfield
Journal:  Metabolism       Date:  2004-11       Impact factor: 8.694

4.  Influence of cardiorespiratory fitness on the association between C-reactive protein and metabolic syndrome prevalence in racially diverse women.

Authors:  Michael J LaMonte; Barbara E Ainsworth; J Larry Durstine
Journal:  J Womens Health (Larchmt)       Date:  2005-04       Impact factor: 2.681

5.  Serum levels of the adipokine vaspin in relation to metabolic and renal parameters.

Authors:  Jeannette Seeger; Michaela Ziegelmeier; Anette Bachmann; Ulrike Lössner; Jürgen Kratzsch; Matthias Blüher; Michael Stumvoll; Mathias Fasshauer
Journal:  J Clin Endocrinol Metab       Date:  2007-10-23       Impact factor: 5.958

6.  Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002.

Authors:  C Herder; J Baumert; B Thorand; W Koenig; W de Jager; C Meisinger; T Illig; S Martin; H Kolb
Journal:  Diabetologia       Date:  2006-03-11       Impact factor: 10.122

7.  A quantitative analysis of the relationship between habitual energy expenditure, fitness and the metabolic cardiovascular syndrome.

Authors:  N J Wareham; S J Hennings; C D Byrne; C N Hales; A M Prentice; N E Day
Journal:  Br J Nutr       Date:  1998-09       Impact factor: 3.718

Review 8.  Obesity, insulin resistance, and cardiovascular disease.

Authors:  Gerald Reaven; Fahim Abbasi; Tracey McLaughlin
Journal:  Recent Prog Horm Res       Date:  2004

9.  Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA/KORA studies.

Authors:  K Kempf; B Rose; T Illig; W Rathmann; K Strassburger; B Thorand; C Meisinger; H-E Wichmann; C Herder; C Vollmert
Journal:  Exp Clin Endocrinol Diabetes       Date:  2008-08-25       Impact factor: 2.949

10.  Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome.

Authors:  Timo A Lakka; David E Laaksonen; Hanna-Maaria Lakka; Niko Männikkö; Leo K Niskanen; Rainer Rauramaa; Jukka T Salonen
Journal:  Med Sci Sports Exerc       Date:  2003-08       Impact factor: 5.411

View more
  13 in total

Review 1.  Vaspin in obesity and diabetes: pathophysiological and clinical significance.

Authors:  Matthias Blüher
Journal:  Endocrine       Date:  2011-12-03       Impact factor: 3.633

2.  Serum vaspin levels are associated with physical activity or physical fitness in Japanese: a pilot study.

Authors:  Nobuyuki Miyatake; Jun Wada; Atsuko Nakatsuka; Noriko Sakano; Sanae Teshigawara; Motohiko Miyachi; Izumi Tabata; Takeyuki Numata
Journal:  Environ Health Prev Med       Date:  2014-01-04       Impact factor: 3.674

3.  A Short-Term Paleolithic Dietary Intervention Does Not Alter Adipokines Linked to Adiposity.

Authors:  Rachel M Graff; Kristofer Jennings; Natalie A Davies; Andres E Carrillo; Emily C Lavoy; Edward J Ryan; Melissa M Markofski
Journal:  Int J Exerc Sci       Date:  2021-04-01

4.  Inflammation, a link between obesity and cardiovascular disease.

Authors:  Zhaoxia Wang; Tomohiro Nakayama
Journal:  Mediators Inflamm       Date:  2010-08-05       Impact factor: 4.711

5.  Short-Term Impact of Laparoscopic Sleeve Gastrectomy on Serum Cartonectin and Vaspin Levels in Obese Subjects.

Authors:  Doaa M Ibrahim; Nagwa R Mohamed; Tarek A Fouad; Ahmed F Soliman
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

Review 6.  The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.

Authors:  Gillian A Kelly-Robinson; James A Reihill; Fionnuala T Lundy; Lorcan P McGarvey; John C Lockhart; Gary J Litherland; Keith D Thornbury; S Lorraine Martin
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

Review 7.  Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development.

Authors:  Xavier Escoté; Saioa Gómez-Zorita; Miguel López-Yoldi; Iñaki Milton-Laskibar; Alfredo Fernández-Quintela; J Alfredo Martínez; María J Moreno-Aliaga; María P Portillo
Journal:  Int J Mol Sci       Date:  2017-08-15       Impact factor: 5.923

8.  Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells.

Authors:  Chang Hee Jung; Woo Je Lee; Jenie Yoonoo Hwang; Min Jung Lee; So Mi Seol; Yun Mi Kim; Yoo La Lee; Hyun Sik Kim; Min-Seon Kim; Joong-Yeol Park
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

9.  Vaspin inhibits cytokine-induced nuclear factor-kappa B activation and adhesion molecule expression via AMP-activated protein kinase activation in vascular endothelial cells.

Authors:  Chang Hee Jung; Min Jung Lee; Yu Mi Kang; Yoo La Lee; Hae Kyeong Yoon; Sang-Wook Kang; Woo Je Lee; Joong-Yeol Park
Journal:  Cardiovasc Diabetol       Date:  2014-02-12       Impact factor: 9.951

Review 10.  Obesity, inflammation, and lung injury (OILI): the good.

Authors:  Cheryl Wang
Journal:  Mediators Inflamm       Date:  2014-05-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.